Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID : E-SPERANZA COVID Project study protocol

MLA

Mera Cordero, Francisco, et al. Double-Blind Placebo-Controlled Randomized Clinical Trial to Assess the Efficacy of Montelukast in Mild to Moderate Respiratory Symptoms of Patients with Long COVID : E-SPERANZA COVID Project Study Protocol. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1337029159&authtype=sso&custid=ns315887.

APA

Mera Cordero, F., Bonet Monne, S., Almeda, J., Garcia-Sangenis, A., Cunillera, O., Contreras-Martos, S., Álvarez Muñoz, G., Monfà Escolà, R., Balanzó Joué, M., Morros Pedrós, R., & Salvador-Gonzalez, B. (2022). Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID : E-SPERANZA COVID Project study protocol.

Chicago

Mera Cordero, Francisco, Sara Bonet Monne, J Almeda, Ana Garcia-Sangenis, O Cunillera, Sara Contreras-Martos, Gemma Álvarez Muñoz, et al. 2022. “Double-Blind Placebo-Controlled Randomized Clinical Trial to Assess the Efficacy of Montelukast in Mild to Moderate Respiratory Symptoms of Patients with Long COVID : E-SPERANZA COVID Project Study Protocol.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1337029159&authtype=sso&custid=ns315887.